Infórmanos si algún enlace no funciona o si se ha publicado alguna nueva guía clínica: remi.medicina.intensiva@gmail.com

sábado, 4 de junio de 2011

Enfermedades neuromusculares y polineuropatías; Guillain-Barré, Miastenia gravis; Plasmaféresis, Inmunoterapia

  1. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW. Eur J Neurol 2010; 17: 1-10. [PDF]
  2. Practice parameter: immunotherapy for Guillain-Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Miller RG, Sladky JT, Stevens JC. Neurology 2003; 61(6): 736-740. [PDF]
  3. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Neurology 2011; 76(3): 294-300. [PDF]
  4. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases. Elovaaraa I, Apostolskib S, van Doornc P, Gilhusd NE, Hietaharjue A, Honkaniemif J, van Schaikg IN, Scoldingh N, Soelberg Sørenseniand P, Udd B. Eur J Neurol 2008; 15: 893–890. [PDF

No hay comentarios:

Publicar un comentario en la entrada